TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Bradley J Monk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.